IFNA1 and hepatocellular carcinoma: We suppose that the hepatic activation of ISGs in liver samples from patients with chronic hepatitis C and from HCC patients with HCV infections as a risk factor, i.e., the IFN signature, is promoted by non-type I functional IFNs in the absence of type I IFNs.